Fascial Therapy in Elbow Hemophilic Arthropathy (HeL-Fascial)
Prospective and Multicenter Study to Assess the Safety and Effectiveness of a Physiotherapy Treatment Through Fascial Therapy in Hemophilic Elbow Arthropathy. A Pilot Study.
Introduction: The common clinical manifestations of hemophilia are skeletal muscle bleeds, especially hematomas and hemarthrosis. Repeated episodes of joint bleeding in certain joints, causing a progressive joint deterioration. Secondary disorders to this joint degeneration include: biomechanical alterations, loss of range of movement and periarticular muscle atrophy.
Design. A prospective, multicenter and longitudinal pilot study to evaluate the efficacy of a treatment protocol with fascial therapy applied in patients with hemophilic arthropathy of the elbow.
Aimed: To evaluate the safety and efficacy of a physiotherapy treatment by fascial therapy in patients with hemophilic arthropathy of the elbow Patients: A total of 60 patients with hemophilia and prophylactic treatment will be recruited for inclusion in the study. Patients will be recruited in 6 centers, from different regions of Spain.
Intervention: Each session will last approximately 50 minutes, with three physiotherapy sessions taking place over a period of 3 weeks. The treatment program includes 11 maneuvers that must be administered bilaterally:
Measuring instruments and study variables: goniometric evaluation (range of movement); visual analog scale (joint pain); Haemophilia Joint Health Score (joint status); DASH Questionnaire (functionality of upper limbs); SF-36 Questionnaire (perception of quality of life). At the same time, the study will allow to determine joint bleeding caused by applied physiotherapy treatment.
Expected results: First, it is intended to demonstrate the safety of this physiotherapy technique in patients with hemophilia. Likewise, an improvement in the perception of elbow pain and joint mobility is expected. An improved functionality of the upper limb is also foreseen and with it, an enhanced perception of quality of life of these patients.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Madird
-
Madrid、Madird、西班牙、28029
- Royal Victoria Eugenia Foundation
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patients diagnosed with hemophilia A and B
- Patients adults (over 18 years)
- Patients diagnosed with hemophilic arthropathy of the elbow (by clinical assessment with the Hemophilia Joint Health Score)
- Patients pn prophylactic treatment with FVIII / FIX concentrates.
Exclusion Criteria:
- Patients without ambulation ability
- Patients with inhibitors
- Patients with neurological or cognitive alterations that impede the comprehension of the questionnaires and physical tests
- Patients who have not signed the informed consent document.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:Expermiental group
All patients included in the experimental group should be on prophylactic treatment with FVIII / FIX concentrates.
Likewise, the factor should be administered on the same day that they receive each of the fascial therapy treatment sessions.
Each session will last approximately 50 minutes, with three physiotherapy sessions taking place over a period of 3 weeks.
The treatment program includes 11 maneuvers that must be administered bilaterally:
|
Longitudinal surface sliding maneuver over the superficial fascia in the anterior region of the arm and the forearm. Applied in 3 strokes.
其他名称:
|
无干预:Control group
Subjects included in the control group will not receive physical therapy through fascial therapy and will continue with their usual routine of physical activity and exercise, and with the same pharmacological treatment regimen with FVIII / FIX.
At the end of the study period the intervention will be applied under the same conditions as the experimental group, analyzing the overall sample at the end of the study.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Change from baseline elbow joint bleeding frequency after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
After the first session of physiotherapy patients will be given a self-register where they can record all the observations they feel (from hematomas or hemarthros, to any other discomfort or perception).
Similarly, the principal investigator of the study will monitor all patients within 48 hours after each physical therapy session.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Change from baseline range of motion of elbow after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from range of movement of elbow during treatment and follow-up period at 3 months. The range of motion of the elbow joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia |
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline elbow joint status after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from elbow joint status during treatment and follow-up period at 3 months.
Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline joint pain of elbow after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from joint pain of ankle during treatment and follow-up period at 3 months.The perception of ankle pain will be measured using visual analog scale (scale 0-10).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline upper limb functionality after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from upper limb functionality during treatment and follow-up period at 3 months.
The perception of ankle pain will be measured using DASH Questionnaire.
The Spanish version of this scale used internationally will evaluate upper limb functionality.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline quality of life after treatment and at 3 months
大体时间:Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from quality of life during treatment and follow-up period at 3 months.
The quality of life perception will be measured using SF-36 Questionnaire.
This scale will assess the perception of quality of life of patients included in the study.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
合作者和调查者
出版物和有用的链接
一般刊物
- Cuesta-Barriuso R, Meroño-Gallut J, Donoso-Úbeda E, López-Pina JA, Pérez-Llanes R. Effect of a Fascial Therapy Treatment on Quality of Life in Patients With Hemophilic Elbow Arthropathy: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2022 May;103(5):867-874. doi: 10.1016/j.apmr.2021.12.023. Epub 2022 Jan 23.
- Cuesta-Barriuso R, Perez-Llanes R, Lopez-Pina JA, Donoso-Ubeda E, Merono-Gallut J. Manual therapy reduces the frequency of clinical hemarthrosis and improves range of motion and perceived disability in patients with hemophilic elbow arthropathy. A randomized, single-blind, clinical trial. Disabil Rehabil. 2022 Jul;44(15):3938-3945. doi: 10.1080/09638288.2021.1894607. Epub 2021 Mar 8.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Experimental group的临床试验
-
Centro Hospitalar do PortoUniversity of Trás-os-Montes and Alto Douro; Foundation for Science and Technology, Portugal; Institute...招聘中
-
Amsterdam UMC, location VUmcRed Cross Hospital Beverwijk完全的
-
Case Western Reserve UniversityNational Institutes of Health (NIH); American Heart Association完全的
-
Northern Illinois UniversityUniversity Autonoma de Santo Domingo终止